TABLE OF CONTENTS
1 INTRODUCTION 43
1.1 OBJECTIVES OF THE STUDY 43
1.2 MARKET DEFINITION 43
1.3 OVERVIEW OF GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET 43
1.4 LIMITATIONS 45
1.5 MARKETS COVERED 45
2 MARKET SEGMENTATION 48
2.1 MARKETS COVERED 48
2.2 GEOGRAPHICAL SCOPE 49
2.3 YEARS CONSIDERED FOR THE STUDY 50
2.4 CURRENCY AND PRICING 50
2.5 DBMR TRIPOD DATA VALIDATION MODEL 51
2.6 MULTIVARIATE MODELLING 54
2.7 PRODUCT LIFELINE CURVE 54
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 55
2.9 DBMR MARKET POSITION GRID 56
2.10 MARKET END USERS COVERAGE GRID 57
2.11 VENDOR SHARE ANALYSIS 58
2.12 SECONDARY SOURCES 59
2.13 ASSUMPTIONS 59
3 EXECUTIVE SUMMARY 60
4 PREMIUM INSIGHTS 63
4.1 VALUE CHAIN ANALYSIS 65
4.2 SUPPLY CHAIN ANALYSIS 66
4.2.1 RAW MATERIAL PROCUREMENT 66
4.2.2 MANUFACTURING AND DISTRIBUTION 66
4.2.3 END USERS 66
4.3 PORTER'S FIVE FORCES 67
4.3.1 BARGAINING POWER OF SUPPLIERS 67
4.3.2 BARGAINING POWER OF BUYERS/CONSUMERS 67
4.3.3 THREAT OF NEW ENTRANTS 68
4.3.4 THREAT OF SUBSTITUTES PRODUCTS 68
4.3.5 INTENSITY OF COMPETITIVE RIVALRY 68
4.4 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 69
4.5 OVERVIEW OF TECHNOLOGICAL INNOVATIONS 70
4.6 INDUSTRY TRENDS AND FUTURE PERSPECTIVE 71
4.7 FACTORS INFLUENCING PURCHASING DECISION OF END-USERS 72
5 PRICING ANALYSIS 73
6 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET, REGULATIONS 74
7 MARKET OVERVIEW, GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET 76
7.1 DRIVERS 78
7.1.1 GROWING PRODUCTION OF FEED ADDITIVES 78
7.1.2 INCREASING AWARENESS OF THE BENEFITS OF PLANT-BASED PRODUCTS 78
7.1.3 INCREASED DEMAND AND CONSUMPTION OF LIVESTOCK-BASED PRODUCTS 79
7.2 RESTRAINTS 79
7.2.1 STRICT RESTRICTIONS AND REGULATIONS IMPOSED BY GOVERNMENT 79
7.2.2 INADEQUATE RAW MATERIAL AVAILABILITY 80
7.3 OPPORTUNITIES 80
7.3.1 GROWING COMMERCIAL APPLICATION 80
7.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES 80
7.4 CHALLENGES 81
7.4.1 AVAILABILITY OF FEED ADDITIVE SUBSTITUTES 81
7.4.2 PRODUCT LABELLING AND TRADE ISSUES 81
8 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET, BY PRODUCT 82
8.1 OVERVIEW 83
8.1.1 BACTERIA BASED 86
8.1.1.1 BACILLUS 87
8.1.1.1.1 SUBTILIS 88
8.1.1.1.2 LICHENIFORMIS 88
8.1.1.1.3 AMYLOLIQUEFACIENS 88
8.1.1.1.4 MEGATERIUM 88
8.1.1.1.5 MESENTRICUS 88
8.1.1.1.6 POLYMYXA 88
8.1.1.1.7 TOYONENSIS 88
8.1.1.1.8 OTHERS 88
8.1.1.2 LACTOBACILLUS 89
8.1.1.2.1 ACIDOPHILUS 89
8.1.1.2.2 BULGARICUS 89
8.1.1.2.3 REUTERI 89
8.1.1.2.4 CASEI 90
8.1.1.2.5 LACTIS 90
8.1.1.2.6 SALIVARIUS 90
8.1.1.2.7 PLANTARUM 90
8.1.1.2.8 RHAMNOSUS 90
8.1.1.2.9 FERMENTUM 90
8.1.1.2.10 FARCIMINIS 90
8.1.1.2.11 THERMOPHILUS 90
8.1.1.2.12 OTHERS 91
8.1.1.3 BIFIDOBACTERIUM 91
8.1.1.3.1 BIFIDIUM 91
8.1.1.3.2 BIFIDUS 91
8.1.1.3.3 THERMOPHILUS 91
8.1.1.3.4 ANIMALS 91
8.1.1.3.5 OTHERS 92
8.1.1.4 ENTEROCOCCUS 92
8.1.1.5 STREPTOCOCCUS 92
8.1.1.6 CLOSTRIDIUM 92
8.1.1.7 PEDIOCOCCUS 92
8.1.1.7.1 PARVULUS 92
8.1.1.7.2 ACIDILACTICI 92
8.1.1.7.3 OTHERS 93
8.1.2 FUNGI AND YEAST BASED 93
8.1.2.1 SACCHAROMYCES CEREVISIAE 94
8.1.2.2 SACCHAROMYCES BOULARDII 94
8.1.2.3 SACCHAROMYCES SERVISIA 94
8.1.2.4 CANDIDA 94
9 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET, BY TYPE 95
9.1 OVERVIEW 96
9.1.1 SINGLE STRAIN 99
9.1.2 MULTIPLE STRAIN 99
10 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET, BY FORM 101
10.1 OVERVIEW 102
10.1.1 DRY 105
10.1.2 LIQUID 105
11 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET, BY FUNCTION 107
11.1 OVERVIEW 108
11.1.1 GUT HEALTH 111
11.1.2 IMMUNITY 111
11.1.3 NUTRITION 112
11.1.4 FEED INTAKE AND EFFICIENCY 113
11.1.5 YIELD 113
11.1.6 EGG PRODUCTION AND QUALITY 114
11.1.7 OTHERS 115
12 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET, BY APPLICATION 116
12.1 OVERVIEW 117
12.1.1 CHICKS AND POULTS 120
12.1.1.1 BACTERIA BASED 121
12.1.1.2 FUNGI AND YEAST BASED 121
12.1.2 BROILERS 121
12.1.2.1 BACTERIA BASED 122
12.1.2.2 FUNGI AND YEAST BASED 122
12.1.3 LAYERS 122
12.1.3.1 BACTERIA BASED 123
12.1.3.2 FUNGI AND YEAST BASED 123
12.1.4 BREEDERS 123
12.1.4.1 BACTERIA BASED 124
12.1.4.2 FUNGI AND YEAST BASED 124
12.1.5 OTHERS 124
13 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET, BY REGION 125
13.1 OVERVIEW 126
13.2 ASIA-PACIFIC 131
13.2.1 CHINA 140
13.2.2 INDIA 144
13.2.3 JAPAN 148
13.2.4 INDONESIA 152
13.2.5 THAILAND 156
13.2.6 MALAYSIA 160
13.2.7 SOUTH KOREA 164
13.2.8 AUSTRALIA 168
13.2.9 SINGAPORE 172
13.2.10 PHILIPPINES 176
13.2.11 NEW ZEALAND 180
13.2.12 VIETNAM 184
13.2.13 REST OF ASIA-PACIFIC 188
13.3 NORTH AMERICA 189
13.3.1 U.S. 200
13.3.2 MEXICO 206
13.3.3 CANADA 212
13.4 EUROPE 218
13.4.1 GERMANY 227
13.4.2 RUSSIA 232
13.4.3 TURKEY 236
13.4.4 ITALY 240
13.4.5 U.K. 244
13.4.6 FRANCE 248
13.4.7 POLAND 252
13.4.8 SPAIN 256
13.4.9 SWITZERLAND 260
13.4.10 NETHERLANDS 264
13.4.11 BELGIUM 268
13.4.12 DENMARK 272
13.4.13 SWEDEN 276
13.4.14 REST OF EUROPE 280
13.5 SOUTH AMERICA 281
13.5.1 BRAZIL 292
13.5.2 ARGENTINA 298
13.5.3 REST OF SOUTH AMERICA 304
13.6 MIDDLE EAST AND AFRICA 305
13.6.1 SOUTH AFRICA 316
13.6.2 SAUDI ARABIA 323
13.6.3 KUWAIT 330
13.6.4 U.A.E. 337
13.6.5 REST OF MIDDLE EAST AND AFRICA 343
14 GLOBAL POULTRY PROBIOTIC INGREDIENTS MARKET: COMPANY LANDSCAPE 344
14.1 COMPANY SHARE ANALYSIS: GLOBAL 344
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 345
14.3 COMPANY SHARE ANALYSIS: EUROPE 346
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 347
15 SWOT ANALYSIS 348
16 COMPANY PROFILE 349
16.1 LALLEMAND INC 349
16.1.1 COMPANY SNAPSHOT 349
16.1.2 COMPANY SHARE ANALYSIS 349
16.1.3 PRODUCT PORTFOLIO 350
16.1.4 RECENT DEVELOPMENT 350
16.2 EVONIK INDUSTRIES AG 351
16.2.1 COMPANY SNAPSHOT 351
16.2.2 REVENUE ANALYSIS 351
16.2.3 COMPANY SHARE ANALYSIS 352
16.2.4 PRODUCT PORTFOLIO 352
16.2.5 RECENT DEVELOPMENT 352
16.3 ASAHI GROUP HOLDINGS, LTD 353
16.3.1 COMPANY SNAPSHOT 353
16.3.2 REVENUE ANALYSIS 353
16.3.3 COMPANY SHARE ANALYSIS 354
16.3.4 PRODUCT PORTFOLIO 354
16.3.5 RECENT DEVELOPMENT 354
16.4 INTERNATIONAL FLAVORS & FRAGRANCES INC 355
16.4.1 COMPANY SNAPSHOT 355
16.4.2 REVENUE ANALYSIS 355
16.4.3 COMPANY SHARE ANALYSIS 356
16.4.4 PRODUCT PORTFOLIO 356
16.4.5 RECENT DEVELOPMENT 356
16.5 PHILEO BY LESAFFRE 357
16.5.1 COMPANY SNAPSHOT 357
16.5.2 COMPANY SHARE ANALYSIS 357
16.5.3 PRODUCT PORTFOLIO 358
16.5.4 RECENT DEVELOPMENT 358
16.6 ADVANCED ENZYME TECHNOLOGIES 359
16.6.1 COMPANY SNAPSHOT 359
16.6.2 REVENUE ANALYSIS 359
16.6.3 PRODUCT PORTFOLIO 360
16.6.4 RECENT DEVELOPMENT 360
16.7 ALLTECH 361
16.7.1 COMPANY SNAPSHOT 361
16.7.2 PRODUCT PORTFOLIO 361
16.7.3 RECENT DEVELOPMENTS 361
16.8 BIOCAMP 362
16.8.1 COMPANY SNAPSHOT 362
16.8.2 PRODUCT PORTFOLIO 362
16.8.3 RECENT DEVELOPMENT 362
16.9 CHR. HANSEN HOLDING A/S 363
16.9.1 COMPANY SNAPSHOT 363
16.9.2 REVENUE ANALYSIS 363
16.9.3 PRODUCT PORTFOLIO 364
16.9.4 RECENT DEVELOPMENT 364
16.10 INTERNATIONAL ANIMAL HEALTH PRODUCTS 365
16.10.1 COMPANY SNAPSHOT 365
16.10.2 PRODUCT PORTFOLIO 365
16.10.3 RECENT DEVELOPMENT 365
16.11 KEMIN INDUSTRIES, INC 366
16.11.1 COMPANY SNAPSHOT 366
16.11.2 PRODUCT PORTFOLIO 366
16.11.3 RECENT DEVELOPMENT 366
16.12 NOVOZYMES 367
16.12.1 COMPANY SNAPSHOT 367
16.12.2 REVENUE ANALYSIS 367
16.12.3 PRODUCT PORTFOLIO 368
16.12.4 RECENT DEVELOPMENT 368
16.13 PANGOO 369
16.13.1 COMPANY SNAPSHOT 369
16.13.2 PRODUCT PORTFOLIO 369
16.13.3 RECENT DEVELOPMENT 369
16.14 PROVITA ANIMAL HEALTH 370
16.14.1 COMPANY SNAPSHOT 370
16.14.2 PRODUCT PORTFOLIO 370
16.14.3 RECENT DEVELOPMENT 370
16.15 UNIQUE BIOTECH 371
16.15.1 COMPANY SNAPSHOT 371
16.15.2 PRODUCT PORTFOLIO 371
16.15.3 RECENT DEVELOPMENT 371
17 QUESTIONNAIRE 372
18 RELATED REPORTS 375

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.